Guest Contributors
 Annie Martin, SVP, Global Head of Precision Medicine, Novartis |
 Chief Operating Officer, IDT |
 former CEO, Pacific Biosciences |
 Rodrigo Martinez, Chief Marketing and Design Officer at Veritas |
 Program Chair, PMWC |
 |
 Founder, Science Futures |
 President and CEO, My Gene Counsel |
 VP, Boston Healthcare |
 Associate Professor, Leader of the Precision Cancer Medicine Initiative at the Biorepository and Precision Pathology Center at Duke University |
 Dir of Scientific Research, Illumina |
 Director, PGI |
 Matt McLoughlin, VP of Compliance at Scientist.com |
 Founder, Vitrova |
 Partner, Latham & Watkins |
 President, ACLA |
 Karen Miga, DNA biologist and co-lead of the telomere-to-telomere (T2T) consortium UCSC |
 CEO, Calithera |
 Journalist, Author |
 Jordanna Mora, Associate Director Patient Advocacy and Engagement at Alnylam Pharmaceuticals , Inc. |
 CEO, Protagen |
 CEO, Gen9 |
 Founder, InnoThink |
 Mike Murray, Director of Clinical Genomics, Geisinger Health System |
 Founding Director, Systems Biology Center, Max Planck Institute |
